# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $...
Elevance Health (NYSE:ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strate...
JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $628 to ...
Baird analyst Michael Ha initiates coverage on Elevance Health (NYSE:ELV) with a Outperform rating and announces Price Targe...
UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bern...